Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of ProF-001 vs clotrimazole in vulvovaginal candidiasis
2016-004268-21Phase 2Completed
- Sponsor
- ProFem
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Candiplus in vulvovaginal candidiasis (VVC) (4 arms), sponsored by ProFem. Primary endpoint: Combined primary clinical efficacy endpoint dose-response. Started Jan 2017; status: completed.
02
Drugs
Candiplus
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2016-004268-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004268-21.